How to treat recurrent/metastatic head and neck cancer: the economic issue in real-world practice.

about

How to treat recurrent/metastatic head and neck cancer: the economic issue in real-world practice.

Item

http://www.wikidata.org/entity/Q47993949

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

How to treat recurrent/metasta ...... issue in real-world practice.

@en

How to treat recurrent/metasta ...... issue in real-world practice.

@nl

type

Item

label

How to treat recurrent/metasta ...... issue in real-world practice.

@en

How to treat recurrent/metasta ...... issue in real-world practice.

@nl

prefLabel

How to treat recurrent/metasta ...... issue in real-world practice.

@en

How to treat recurrent/metasta ...... issue in real-world practice.

@nl

P1476

How to treat recurrent/metasta ...... issue in real-world practice.

@en

P2093

Peter Mu-Hsin Chang

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2015

Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group.

Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.

Platinum-based chemotherapy plus cetuximab in head and neck cancer.

Cost-effectiveness of adding cetuximab to platinum-based chemotherapy for first-line treatment of recurrent or metastatic head and neck cancer.

Head and neck cancer-specific survival based on socioeconomic status in Asians and Pacific Islanders.

Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial.

Feasibility and safety of dose-dense modified docetaxel-cisplatin or carboplatin and 5-fluorouracil regimen (mTPF) in locally advanced or metastatic head and neck cancers: a retrospective monocentric study.

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.

P304

779-780

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1080/03007995.2017.1282446

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hsueh-Ju Lu

P577

2017-01-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28084109

http://www.w3.org/2001/XMLSchema#string